Jupiter Price To Sales Ratio vs Free Cash Flow Per Share Analysis
| JUNS Stock | USD 9.73 1.13 10.41% |
Jupiter Neurosciences, financial indicator trend analysis is infinitely more than just investigating Jupiter Neurosciences, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jupiter Neurosciences, is a good investment. Please check the relationship between Jupiter Neurosciences, Price To Sales Ratio and its Free Cash Flow Per Share accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jupiter Neurosciences, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Price To Sales Ratio vs Free Cash Flow Per Share
Price To Sales Ratio vs Free Cash Flow Per Share Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jupiter Neurosciences, Price To Sales Ratio account and Free Cash Flow Per Share. At this time, the significance of the direction appears to have no relationship.
The correlation between Jupiter Neurosciences,'s Price To Sales Ratio and Free Cash Flow Per Share is 0.04. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Free Cash Flow Per Share in the same time period over historical financial statements of Jupiter Neurosciences, Common, assuming nothing else is changed. The correlation between historical values of Jupiter Neurosciences,'s Price To Sales Ratio and Free Cash Flow Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Jupiter Neurosciences, Common are associated (or correlated) with its Free Cash Flow Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Per Share has no effect on the direction of Price To Sales Ratio i.e., Jupiter Neurosciences,'s Price To Sales Ratio and Free Cash Flow Per Share go up and down completely randomly.
Correlation Coefficient | 0.04 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Jupiter Neurosciences, stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Jupiter Neurosciences, sales, a figure that is much harder to manipulate than other Jupiter Neurosciences, Common multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Free Cash Flow Per Share
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.Most indicators from Jupiter Neurosciences,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jupiter Neurosciences, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jupiter Neurosciences, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Sales General And Administrative To Revenue is likely to gain to 11.03 in 2024, whereas Selling General Administrative is likely to drop slightly above 2.8 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 638.0K | 233.3K | 210.0K | 199.5K | Total Revenue | 638.0K | 233.3K | 210.0K | 199.5K |
Jupiter Neurosciences, fundamental ratios Correlations
Click cells to compare fundamentals
Jupiter Neurosciences, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Jupiter Stock Analysis
When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.